logo
Share SHARE
FONT-SIZE Plus   Neg

Jazz Pharma To Sell Women's Health Unit To Meda - Quick Facts

Jazz Pharmaceuticals plc (JAZZ) entered into a definitive agreement to sell its women's health business, comprising six products, to Meda, an international specialty pharmaceutical company, for $95 million cash. The sale includes products like Elestrin, Gastrocrom, Natelle One, AVC Cream, Gesticare DHA and Urelle. Net sales for these products in 2011 totaled $30.4 million.

According to the transaction, Meda would offer positions to nearly 60 Jazz Pharmaceuticals employees who directly support these products. Jazz Pharmaceuticals expects to recognize a non-recurring gain on the sale in the fourth quarter of 2012. The company intends to provide more detail about the financial impact of the transaction after closing. The transaction may close in the fourth quarter of 2012.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Grab, the Singapore-based ride hailing company and Uber's biggest Asian rival, said Monday that Chinese ride-sharing company Didi Chuxing and Japan's SoftBank Group Corp. will invest a combined $2 billion to lead Grab's new financing round. Delta Air Lines is allowing some passengers use fingerprints instead of their boarding passes. The pilot program at the Reagan Washington National Airport or DCA will allow members of Delta's SkyMiles loyalty program and enrolled in Clear, a third-party biometric screening program, to use fingerprints as proof of identity to board their plane, the company said in a statement. Oilfield services company Halliburton Co. reported Monday a profit in its second quarter, compared to a hefty loss last year, boosted mainly by strong demand in North America. In pre-market activity on the NYSE, Halliburton shares were gaining 3.9 percent.
comments powered by Disqus
Follow RTT